MAPT and Alzheimer disease: In this regard, a unique microglial signature exclusively present in AD, i.e., the “disease-associated microglia” (DAM), was first described in proximity to Aβ plaques in 6 month-old AD mice [56], and then confirmed in models of tau pathology and post-mortem human tissues from AD patients [57].